These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15279580)

  • 1. New trends in the design of drugs against Alzheimer's disease.
    Francotte P; Graindorge E; Boverie S; de Tullio P; Pirotte B
    Curr Med Chem; 2004 Jul; 11(13):1757-78. PubMed ID: 15279580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of pharmacotherapy in Alzheimer's disease.
    Yamada K; Ren X; Nabeshima T
    Jpn J Pharmacol; 1999 May; 80(1):9-14. PubMed ID: 10446751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of β-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer's Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase.
    Basha SJ; Mohan P; Yeggoni DP; Babu ZR; Kumar PB; Rao AD; Subramanyam R; Damu AG
    Mol Pharm; 2018 Jun; 15(6):2206-2223. PubMed ID: 29745222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
    Doraiswamy PM
    CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease.
    Kumar K; Kumar A; Keegan RM; Deshmukh R
    Biomed Pharmacother; 2018 Feb; 98():297-307. PubMed ID: 29274586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs.
    Grundman M; Corey-Bloom J; Thal LJ
    J Neural Transm Suppl; 1998; 53():255-75. PubMed ID: 9700663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multifunctional anti-inflammatory drugs used in the therapy of Alzheimer's disease.
    Shi S; Wang Z; Qiao Z
    Curr Med Chem; 2013; 20(20):2583-8. PubMed ID: 23590711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medicinal and chemical approaches to focused search of agents for treatment and therapy of Alzheimer disease].
    Bachurin SO
    Vopr Med Khim; 2001; 47(2):155-97. PubMed ID: 11450439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in the drug treatment of Alzheimer's disease.
    Sramek JJ; Cutler NR
    Drugs Aging; 1999 May; 14(5):359-73. PubMed ID: 10408736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.
    León R; Garcia AG; Marco-Contelles J
    Med Res Rev; 2013 Jan; 33(1):139-89. PubMed ID: 21793014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic therapies for Alzheimer's disease: progress and prospects.
    Palmer AM
    Curr Opin Investig Drugs; 2003 Jul; 4(7):820-5. PubMed ID: 14619403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide: target for therapeutic strategies in Alzheimer's disease.
    Fernandez AP; Pozo-Rodrigalvarez A; Serrano J; Martinez-Murillo R
    Curr Pharm Des; 2010; 16(25):2837-50. PubMed ID: 20698819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease: emerging trends in small molecule therapies.
    Mohamed T; Rao PP
    Curr Med Chem; 2011; 18(28):4299-320. PubMed ID: 21861820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential therapeutic agents against Alzheimer's disease from natural sources.
    Park SY
    Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutics of Alzheimer's disease: Past, present and future.
    Anand R; Gill KD; Mahdi AA
    Neuropharmacology; 2014 Jan; 76 Pt A():27-50. PubMed ID: 23891641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Molecule Natural Products and Alzheimer's Disease.
    Wu X; Cai H; Pan L; Cui G; Qin F; Li Y; Cai Z
    Curr Top Med Chem; 2019; 19(3):187-204. PubMed ID: 30714527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
    Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
    Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic drugs in pharmacotherapy of Alzheimer's disease.
    Camps P; Muñoz-Torrero D
    Mini Rev Med Chem; 2002 Feb; 2(1):11-25. PubMed ID: 12369954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future therapeutic approaches to Alzheimer's disease.
    Davis KL
    J Clin Psychiatry; 1998; 59 Suppl 11():14-6. PubMed ID: 9731545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic treatment of cognition in Alzheimer's dementia.
    Farlow MR; Evans RM
    Neurology; 1998 Jul; 51(1 Suppl 1):S36-44; discussion S65-7. PubMed ID: 9674761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.